INDICATIONS AND USAGE: 1. After washing your face, apply a toner to clean up your skin. 2. Open the pouch and remove both films separating the upper and lower face. 3. Attach the transparent film-removed surface of the mask to the skin. (Does not matter which side of mask is adhered onto skin.) 4. Remove the mask about 20-40min later, and tap the face lightly for the skin to absorb the contents of the mask remaini...
Dosage and administration : Putting the product on the skin for 20-40 minutes, remove the mask and spread the remaining product evenly over the entire face.
Active ingredient : GLYCERIN 30%
Inactive ingredient : WATER, HUMAN BONE MARROW STEM CELL CONDITIONED MEDIA, NIACINAMIDE, CERATONIA SILIQUA GUM, BUTYLENE GLYCOL, SODIUM HYALURONATE, PHENOXYETHANOL, ETHYLHEXYLGLYCERIN, CHONDRUS CRISPUS (CARRAGEENAN), 1,2-HEXANEDIOL, PEG-60 HYDROGENATED CASTOR OIL, BETAINE, ALGIN, PHENYL TRIMETHICONE, DIPOTASSIUM GLYCYRRHIZATE, SODIUM POLYACRYLATE, METHYLPARABEN, PORTULACA OLERACEA EXTRACT, ADENOSINE, DISODIUM EDTA, POTASSIUM HYDROXIDE, FRAGRANCE, MANNAN
Purpose : Skin Protectant
Warning : Keep out of reach of children and babies. For external use only. Avoid contact with eyes. Discontinue use if signs of irritation and/or rash appear.
Keep out of reach of children and babies.
INDICATIONS AND USAGE:
1. After washing your face, apply a toner to clean up your skin.
2. Open the pouch and remove both films separating the upper and lower face.
3. Attach the transparent film-removed surface of the mask to the skin. (Does not matter which side of mask is adhered onto skin.)
4. Remove the mask about 20-40min later, and tap the face lightly for the skin to absorb the contents of the mask remaining on the face.
Dosage and administration : Putting the product on the skin for 20-40 minutes, remove the mask and spread the remaining product evenly over the entire face.
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60949-110-01 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-37cb-60a7-e053-dbdaa90a05bd | 4711bfd3-6cb0-41c8-b2b9-92147e781bf3 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60949-110-01 | By Pharmicell Lab Beaucell Dual Hydrogel Mask | 5 in 1 CARTON | PATCH | 5 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GLYCERIN | ACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| GLYCERIN | ACTIVE MOIETY | PDC6A3C0OX | 2 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60949-110 | 60949-110-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | ACTIB |
| WATER | 059QF0KO0R | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b98f36fc-f9da-4699-b2cc-88c7dc1076cc | 4711bfd3-6cb0-41c8-b2b9-92147e781bf3 | 2013-07-09 | Warnings | b98f36fc-f9da-4699-b2cc-88c7dc1076cc 4711bfd3-6cb0-41c8-b2b9-92147e781bf3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.